- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Telehealth Intervention Helps to Combat Opioid Use Disorder and Chronic Pain
A randomized clinical trial published in the Journal of American Medical Association discovered that Mindfulness-Oriented Recovery Enhancement (MORE) could significantly enhance outcomes for individuals suffering with opioid use disorder (OUD) and chronic pain. This study comes as a response to the limitations of Methadone Treatment (MT) that often falls short in addressing the emotional dysregulation, pain, and reward processing deficits that contribute to OUD.
This research was conducted from August 2020 to June 2022 and enlisted 154 participants in New Jersey who underwent Methadone Treatment for OUD and experiencing chronic pain. The participants were divided into a group receiving Methadone Treatment as usual care and another receiving telehealth MORE in addition to usual care. The MORE group attended 8 weekly, 2-hour telehealth sessions, focusing on mindfulness, reappraisal, and savoring techniques.
The participants in the MORE plus usual care group exhibited significantly less return to drug use and lower dropout rates from Methadone Treatment when compared to those receiving usual care only. The hazard ratio for return to drug use was 0.58 (95% CI, 0.37-0.90), and for Methadone Treatment dropout, it was 0.41 (95% CI, 0.18-0.96). MORE participants also had fewer days of drug use, better methadone adherence, and experienced reductions in depression and pain compared to the usual care group.
Telehealth MORE demonstrated its feasibility and critical impact on critical aspects of OUD management which ranged from drug use and treatment retention to pain and emotional well-being in patients. These findings highlight the potential of innovative telehealth approaches in addressing the complex interplay of addiction and chronic pain which helps in managing opioid use disorder.
Reference:
Cooperman, N. A., Lu, S.-E., Hanley, A. W., Puvananayagam, T., Dooley-Budsock, P., Kline, A., & Garland, E. L. (2023). Telehealth Mindfulness-Oriented Recovery Enhancement vs Usual Care in Individuals With Opioid Use Disorder and Pain. In JAMA Psychiatry. American Medical Association (AMA). https://doi.org/10.1001/jamapsychiatry.2023.5138
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751